Several American states voted to legalize cannabis this November 2020. Will they succeed?
Psilocybin’s emergence as a valuable tool for mental health research has been a huge breakthrough for the field. But how do researchers get their hands on this heavily regulated substance? We talked to Tim Moore, CEO of Havn Life Sciences, a company that produces psychoactive compounds from plants and fungi, to find out more.
The role that psychedelic therapeutics could play in tackling many intractable mental health conditions has finally been recognized by mainstream medicine. To find out more, we spoke to Carol Routledge, chief medical and scientific officer at Small Pharma.
This three-part series will take a closer look at the real-world, practical assessment of Colorado’s intent to implement these new regulations and their implications for other states that will inevitably follow suit.
With the cannabis industry’s increasing acceptance and regulation, mass spectrometry has also become a technique near-indispensable to the analytical scientists working within the cannabis testing sector.
Provided by the Eighth Revolution team, the Cannabinoid Corner looks to provide a broader understanding of the entire cannabinoid industry as they see it.
Automation ensures quality, repeatability, and maximum output in lab testing and oil extraction, writes Mike Severino, sales manager at Festo.